14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.82 $2.46 Friday, 3rd May 2024 PRQR stock ended at $2.01. This is 1.01% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.06% from a day low at $1.97 to a day high of $2.05.
90 days $1.82 $2.69
52 weeks $1.11 $3.29

Historical ProQR Therapeutics N.V. prices

Date Open High Low Close Volume
Jan 17, 2024 $2.48 $3.29 $2.48 $2.85 3 384 563
Jan 16, 2024 $2.24 $2.53 $2.22 $2.50 716 528
Jan 12, 2024 $2.02 $2.23 $1.99 $2.23 310 937
Jan 11, 2024 $1.93 $2.04 $1.93 $2.01 165 353
Jan 10, 2024 $1.96 $2.04 $1.88 $1.98 159 086
Jan 09, 2024 $2.00 $2.05 $1.94 $1.98 105 482
Jan 08, 2024 $2.02 $2.07 $1.94 $1.99 201 983
Jan 05, 2024 $2.03 $2.06 $2.00 $2.03 87 848
Jan 04, 2024 $2.04 $2.10 $1.98 $2.00 143 393
Jan 03, 2024 $2.08 $2.12 $2.01 $2.04 114 798
Jan 02, 2024 $2.00 $2.14 $1.95 $2.08 202 476
Dec 29, 2023 $1.95 $2.04 $1.92 $1.98 157 197
Dec 28, 2023 $2.00 $2.00 $1.90 $1.97 177 420
Dec 27, 2023 $2.01 $2.03 $1.95 $2.01 209 333
Dec 26, 2023 $1.91 $2.02 $1.90 $2.01 133 974
Dec 22, 2023 $2.03 $2.06 $1.87 $1.90 208 527
Dec 21, 2023 $2.02 $2.21 $2.00 $2.01 116 236
Dec 20, 2023 $2.18 $2.20 $1.94 $1.96 419 930
Dec 19, 2023 $2.23 $2.27 $2.19 $2.21 277 982
Dec 18, 2023 $2.17 $2.28 $2.17 $2.21 289 468
Dec 15, 2023 $2.04 $2.16 $2.04 $2.15 284 690
Dec 14, 2023 $2.03 $2.07 $2.00 $2.04 191 211
Dec 13, 2023 $2.03 $2.07 $1.99 $2.04 146 355
Dec 12, 2023 $1.99 $2.09 $1.96 $2.05 245 537
Dec 11, 2023 $1.98 $2.02 $1.91 $1.99 122 465
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT